Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.80)
# 717
Out of 5,042 analysts
515
Total ratings
43.77%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Maintains: Buy | $16 → $17 | $14.99 | +13.41% | 20 | Oct 31, 2025 | |
| AXGN Axogen | Maintains: Buy | $25 → $26 | $22.58 | +15.15% | 2 | Oct 30, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $3.99 | +125.56% | 20 | Oct 22, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $19 | $11.42 | +66.37% | 28 | Oct 8, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $33 → $36 | $19.35 | +86.05% | 16 | Oct 7, 2025 | |
| ICCM IceCure Medical | Maintains: Buy | $2 → $2.5 | $0.74 | +239.01% | 23 | Oct 7, 2025 | |
| RGNX REGENXBIO | Reiterates: Buy | $34 | $11.75 | +189.36% | 13 | Oct 7, 2025 | |
| VNRX VolitionRx | Reiterates: Buy | $2.5 | $0.42 | +492.84% | 3 | Sep 30, 2025 | |
| HROW Harrow | Reiterates: Buy | $64 | $36.51 | +75.29% | 6 | Sep 29, 2025 | |
| KALA KALA BIO | Downgrades: Neutral | n/a | $0.80 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.75 | +154.55% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $98 | $110.00 | -10.91% | 21 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $98 | $88.10 | +11.24% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.90 | +79.49% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.83 | +161.44% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.41 | +314.94% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.60 | +150.00% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $4.19 | +114.80% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.71 | +195.20% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $1.75 | +528.57% | 2 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $54 | $28.65 | +88.48% | 5 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.12 | +156.41% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $32 | $27.95 | +14.51% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $13 | $5.74 | +126.48% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $12.87 | +78.71% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.18 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.01 | +296.24% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $3.98 | +1,784.42% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $11.90 | +34.51% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $1.76 | +184.09% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.55 | +88.48% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $14.85 | +68.35% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $8.85 | +340.68% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.39 | +116.61% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.56 | +435.71% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.43 | +133.10% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.24 | +141.70% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.86 | +948.95% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.46 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $5.45 | +9,074.31% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.33 | +3,245.50% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.39 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $12.38 | +287.72% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $75.11 | -74.70% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.20 | - | 2 | Apr 16, 2020 |
Bausch + Lomb
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $14.99
Upside: +13.41%
Axogen
Oct 30, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $22.58
Upside: +15.15%
Alpha Tau Medical
Oct 22, 2025
Reiterates: Buy
Price Target: $9
Current: $3.99
Upside: +125.56%
Ocular Therapeutix
Oct 8, 2025
Maintains: Buy
Price Target: $15 → $19
Current: $11.42
Upside: +66.37%
Oculis Holding AG
Oct 7, 2025
Maintains: Buy
Price Target: $33 → $36
Current: $19.35
Upside: +86.05%
IceCure Medical
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.74
Upside: +239.01%
REGENXBIO
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $11.75
Upside: +189.36%
VolitionRx
Sep 30, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.42
Upside: +492.84%
Harrow
Sep 29, 2025
Reiterates: Buy
Price Target: $64
Current: $36.51
Upside: +75.29%
KALA BIO
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.80
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.75
Upside: +154.55%
Sep 15, 2025
Maintains: Buy
Price Target: $100 → $98
Current: $110.00
Upside: -10.91%
Sep 12, 2025
Maintains: Buy
Price Target: $90 → $98
Current: $88.10
Upside: +11.24%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $3.90
Upside: +79.49%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.83
Upside: +161.44%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.60
Upside: +150.00%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $4.19
Upside: +114.80%
Aug 20, 2025
Reiterates: Buy
Price Target: $8
Current: $2.71
Upside: +195.20%
Aug 18, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $1.75
Upside: +528.57%
Aug 18, 2025
Maintains: Buy
Price Target: $53 → $54
Current: $28.65
Upside: +88.48%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.12
Upside: +156.41%
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $32
Current: $27.95
Upside: +14.51%
Aug 7, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $5.74
Upside: +126.48%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $12.87
Upside: +78.71%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.18
Upside: -
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.01
Upside: +296.24%
Jul 18, 2025
Downgrades: Neutral
Price Target: $75
Current: $3.98
Upside: +1,784.42%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $11.90
Upside: +34.51%
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $9.55
Upside: +88.48%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $14.85
Upside: +68.35%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $8.85
Upside: +340.68%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.39
Upside: +116.61%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.56
Upside: +435.71%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.43
Upside: +133.10%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.24
Upside: +141.70%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.86
Upside: +948.95%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.46
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $5.45
Upside: +9,074.31%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.33
Upside: +3,245.50%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.39
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $12.38
Upside: +287.72%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $75.11
Upside: -74.70%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -